Published in Parasite Immunol on December 19, 2007
Severe malarial anemia: innate immunity and pathogenesis. Int J Biol Sci (2011) 1.65
Genetic polymorphisms linked to susceptibility to malaria. Malar J (2011) 1.29
MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J Infect Dis (2009) 1.11
Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int J Biol Sci (2011) 0.99
Predictive value of lymphocytopenia and the neutrophil-lymphocyte count ratio for severe imported malaria. Malar J (2013) 0.94
Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India. BMC Res Notes (2009) 0.88
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity. Clin Vaccine Immunol (2010) 0.83
Macrophage migration inhibitory factor in protozoan infections. J Parasitol Res (2012) 0.81
Variations in ncRNA gene LOC284889 and MIF-794CATT repeats are associated with malaria susceptibility in Indian populations. Malar J (2013) 0.78
Leukogram Profile and Clinical Status in vivax and falciparum Malaria Patients from Colombia. J Trop Med (2015) 0.75
Early immune regulatory changes in a primary controlled human Plasmodium vivax infection: CD1c(+) mDC maturation arrest, induction of the kynurenine pathway and regulatory T cell activation. Infect Immun (2017) 0.75
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature (1993) 5.60
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature (2000) 3.81
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry (1994) 3.58
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature (2002) 3.10
A central role for P48/45 in malaria parasite male gamete fertility. Cell (2001) 2.73
Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis (1994) 2.61
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med (1999) 2.35
Continuing medical education and continuing professional development: international comparisons. BMJ (2000) 2.12
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med (2005) 2.10
The crystal structure of d(G-G-G-G-C-C-C-C). A model for poly(dG).poly(dC). J Mol Biol (1985) 2.03
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med (1996) 1.99
New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med (2001) 1.95
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis (1995) 1.88
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. N Engl J Med (1994) 1.81
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum (1993) 1.79
Coping with the negative therapeutic response in psychosocial problems in family medicine. Can J Psychiatry (1983) 1.78
The results of a randomized trial of a quality improvement intervention in the care of patients with heart failure. The MISCHF Study Investigators. Am J Med (2000) 1.78
High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res (2001) 1.70
Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. Ann Rheum Dis (2005) 1.64
Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis (1992) 1.62
Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med (1996) 1.61
Thyroid function in patients with proteinuria. Neth J Med (2008) 1.61
Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma. Endocr Relat Cancer (2011) 1.58
The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis (2007) 1.58
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med (1995) 1.55
Estimates of the infectious reservoir of Plasmodium falciparum malaria in The Gambia and in Tanzania. Trans R Soc Trop Med Hyg (2000) 1.55
Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.54
Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med (1994) 1.53
Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya. Trop Med Int Health (2003) 1.53
Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis (1995) 1.50
Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res (1999) 1.49
CSF levels of angiogenesis-related proteins in patients with leptomeningeal metastases. Neurology (2005) 1.47
Physical therapists' perceptions of the roles of the physical therapist assistant. Phys Ther (1994) 1.45
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
The crystal structure of d(GGATGGGAG): an essential part of the binding site for transcription factor IIIA. Nature (1986) 1.43
Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis (1995) 1.43
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA. Vaccine (2009) 1.41
The Asp299Gly Toll-like receptor 4 polymorphism in advanced aortic atherosclerosis. Neth J Med (2007) 1.40
Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry (1997) 1.40
Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab (2009) 1.39
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia. J Clin Microbiol (2010) 1.38
Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis (1994) 1.37
Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect Immun (2000) 1.37
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci (2009) 1.36
The Mechanism of Bacterial and Fungus Growth Inhibition by 2-Methyl-1,4-Naphthoquinone. J Bacteriol (1946) 1.36
Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. Ann Rheum Dis (2005) 1.35
The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector. Antimicrob Agents Chemother (2012) 1.35
Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. Am J Trop Med Hyg (2001) 1.34
Skilled birth attendance: what does it mean and how can it be measured? A clinical skills assessment of maternal and child health workers in Nepal. Int J Gynaecol Obstet (2005) 1.34
Retinal remodeling. Jpn J Ophthalmol (2012) 1.32
Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals. Clin Exp Immunol (2011) 1.32
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother (1995) 1.31
Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis (2008) 1.30
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis (2008) 1.28
Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A (1997) 1.28
Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J Infect Dis (1994) 1.26
Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Krüppel-like factor 2. Atherosclerosis (2010) 1.26
Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med (Berl) (1998) 1.24
Induction of immunoglobulin synthesis by interleukin 2 is T4+/T8- cell dependent. A role for interleukin 2 in the pokeweed mitogen-driven system. Eur J Immunol (1985) 1.24
An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol (2000) 1.23
Does QI work? The Management to Improve Survival in Congestive Heart Failure (MISCHF) study. Jt Comm J Qual Improv (1996) 1.19
The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest (2000) 1.19
Encephalocytozoon intestinalis-specific monoclonal antibodies for laboratory diagnosis of microsporidiosis. J Clin Microbiol (1996) 1.18
Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol (1998) 1.18
Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem (2000) 1.17
Sexual-stage antibody responses to P. falciparum in endemic populations. Curr Mol Med (2006) 1.16
Methylated genes as new cancer biomarkers. Eur J Cancer (2009) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
Angiogenesis, hypoxia and VEGF expression during tumour growth in a human xenograft tumour model. Microvasc Res (2008) 1.15
Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost (1989) 1.12
Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol (2001) 1.12
Autophagy activity is up-regulated in adipose tissue of obese individuals and modulates proinflammatory cytokine expression. Endocrinology (2012) 1.11
Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers. Parasite Immunol (2006) 1.11
A longitudinal study of immune responses to Plasmodium falciparum sexual stage antigens in Tanzanian adults. Parasite Immunol (2007) 1.11
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer (1994) 1.10
STUDIES ON THE MECHANISM OF ANTIBACTERIAL ACTION OF 2-METHYL-1,4-NAPHTHOQUINONE. Science (1945) 1.10
Serum interleukin-6 and C reactive protein responses in patients after laparoscopic or conventional cholecystectomy. Eur J Surg (1992) 1.07
Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections. Clin Exp Immunol (2003) 1.05
How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol (2010) 1.05
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group. Antimicrob Agents Chemother (1991) 1.03
Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol (2001) 1.03
Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers. Cancer Res (1991) 1.03
Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol Med Microbiol (1999) 1.03
Pro-inflammatory cytokines in patients with essential hypertension. Eur J Clin Invest (2001) 1.02
Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med Mycol (1999) 1.02
Reduced adrenal response and increased mortality after systemic Klebsiella pneumoniae infection in interleukin-6-deficient mice. Eur Cytokine Netw (2002) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur J Clin Invest (2000) 1.01
Antibiotics in sepsis. Intensive Care Med (2001) 1.01
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol (1988) 1.01